44 search results for: Prurigo Nodularis

Patients With <b>Prurigo</b> <b>Nodularis</b> Have a High Prevalence of Atopic and Non-Atopic Comorbidities​
Dermatology
Patients With Prurigo Nodularis Have a High Prevalence of Atopic and Non-Atopic Comorbidities​
expert video

Listen as Dr. Sarina Elmariah explores the comorbidities associated with prurigo nodularis.

View more
<b>Prurigo</b> <b>Nodularis</b> Is a Challenging Diagnosis
Dermatology
Prurigo Nodularis Is a Challenging Diagnosis
expert video

Join Dr. Sarina Elmariah as she discusses the challenges in diagnosing prurigo nodularis.

View more
<b>Prurigo</b> <b>Nodularis</b> Management Goals: From Itch Control to Improved Quality of Life
Dermatology
Prurigo Nodularis Management Goals: From Itch Control to Improved Quality of Life
expert video

Tune in as Dr. Sarina Elmariah describes the management goals for patients with prurigo nodularis.

View more
Neuroimmune Dysfunction Is Critical in the Pathophysiology of <b>Prurigo</b> <b>Nodularis</b>
Dermatology
Neuroimmune Dysfunction Is Critical in the Pathophysiology of Prurigo Nodularis
expert video

Dr. Sarina Elmariah explains the importance of neuroimmune crosstalk in the development of prurigo nodularis.

View more
Transforming <b>Prurigo</b> <b>Nodularis</b> Care in 2026: New Real-World Evidence for Comprehensive Care and Treatment Optimization
Dermatology
Transforming Prurigo Nodularis Care in 2026: New Real-World Evidence for Comprehensive Care and Treatment Optimization
expert video

Join Drs. Sarina Elmariah and Pedro Bastos to explore the full systemic burden of prurigo nodularis, looking beyond the nodules to discover how real-world evidence for approved biologics can inform treatment decisions and long-term care across diverse patient populations.

View more
ADVENT at EADV 2026
On Demand
Transforming Prurigo Nodularis Care in 2026: New Real-World Evidence for Comprehensive Care and Treatment Optimization

Drs. Sarina Elmariah and Pedro Bastos led an engaging ADVENT Industry Hub at EADV 2026 in Vienna, Austria, exploring the full systemic burden of prurigo nodularis (PN) beyond its visible nodules. The session highlighted how real-world evidence for approved biologics can inform treatment decisions and support long-term disease management across diverse patient populations.

The Pathophysiology of <b>Prurigo</b> <b>Nodularis</b>
Dermatology
The Pathophysiology of Prurigo Nodularis
videoanimation

An infographic exploring the pathophysiology of prurigo nodularis and the role of type 2 inflammation.

View more
The Ripple Effect: Uncovering the Hidden Burden and Comorbidities of <b>Prurigo</b> <b>Nodularis</b>
Dermatology
The Ripple Effect: Uncovering the Hidden Burden and Comorbidities of Prurigo Nodularis
expert video

Dr. Sarina Elmariah explores the complex systemic burden of PN, from diverse clinical presentations and delayed diagnosis to the profound impact of itch, sleep disruption, comorbidities, and reduced quality of life.

View more
Beyond Signs and Symptoms: Broadening Treatment Goals in Dermatology
Dermatology
Beyond Signs and Symptoms: Broadening Treatment Goals in Dermatology
expert video

Dr Lawrence Eichenfield explores the broadening of treatment goals for long-term disease control, highlighting the importance of this approach in atopic dermatitis. Drs Culton, Elmariah, and Hawkes expand the discussion to further examine specific management goals unique to each skin disease (bullous pemphigoid, prurigo nodularis, and chronic spontaneous urticaria).

View more
Time to Act: Reducing the Impact of Uncontrolled Disease Through Early Intervention
Dermatology
Time to Act: Reducing the Impact of Uncontrolled Disease Through Early Intervention
expert video

Dr Jason Hawkes describes the importance of early intervention for patients with uncontrolled skin diseases and the effectiveness of evidence-based management strategies, sharing a patient case and his clinical insights with chronic spontaneous urticaria. Drs Eichenfield, Elmariah, and Culton join to review the burdens faced by patients with atopic dermatitis, prurigo nodularis, and bullous pemphigoid, respectively. 

View more
Shared and Distinct: The Role of Type 2 Inflammation in Skin Diseases
Dermatology
Shared and Distinct: The Role of Type 2 Inflammation in Skin Diseases
expert video

Dr Donna Culton walks through the pathophysiology of type 2 inflammation in inflammatory skin diseases, using bullous pemphigoid as an example. Drs Eichenfield, Elmariah, and Hawkes join to discuss the role of type 2 inflammation across atopic dermatitis, prurigo nodularis, and chronic spontaneous urticaria, respectively. 

View more
ADVENT Dermatology Symposium in Denver, CO
On Demand
Cracking the Code: Diagnosing and Managing Skin Diseases With Type 2 Inflammation​

This 2-hour educational program delves into the pivotal role of type 2 inflammation in diverse skin conditions, including atopic dermatitis, prurigo nodularis, bullous pemphigoid, and chronic spontaneous urticaria. It will highlight both shared and distinct disease mechanisms and patient burdens, providing crucial insights for optimizing clinical management strategies. Experts will guide the audience through diverse patient cases to illuminate diagnostic nuances and the pathophysiology of each condition. These cases will also highlight the importance of shared decision-making and the broadening of treatment goals beyond symptom control. Dynamic panel discussion and active audience participation will be facilitated through real-time polling and curated Q&A sessions.